In HNSCC patients with histologically confirmed lymph node metastases (T1–4N1–2M0), the median level of PFN1 in the blood serum was almost two times higher than in patients without regional metastases (T1–4N0M0) (Fig. 1D). Here, PFN1 is linked to metastatic malignant neoplasm in the lymph nodes.